Pharmacogenomics: time to rethink its role in precision medicine.

Willis, J A; Vilar, E

Willis, J A; Vilar, E.

Afiliação

Willis JA; Hematology and Oncology Program, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA.
Vilar E; Department of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, USA; Department of GI Medical Oncology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, USA. Electronic address: evilar@mdanderson.org.

Ann Oncol ; 29(2): 293-295, 2018 02 01.

Article em En | MEDLINE | ID: mdl-29236957

Assuntos

Farmacogenética; Medicina de Precisão; Neoplasias do Colo; Neoplasias Colorretais; Genótipo; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Farmacogenética / Medicina de Precisão Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google